Publications by authors named "Michael Eber"

Claim this Profile
T
The benefits and costs of U.S. employer COVID-19 vaccine mandates.
Maddalena Ferranna, Lisa A Robinson, Daniel Cadarette, Michael R Eber, David E Bloom

Risk Anal· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valuing COVID-19 Morbidity Risk Reductions.
Lisa A Robinson, Michael R Eber, James K Hammitt

J Benefit Cost Anal· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Modest Effects of Fact Boxes on Cancer Screening.
Michael R Eber, Cass R Sunstein, James K Hammitt, Jennifer M Yeh

J Risk Uncertain· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments.
Michael R Eber, Dana P Goldman, Darius N Lakdawalla, Tomas J Philipson, Daryl Pritchard

J Comp Eff Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the value of better diabetes management.
Darius Lakdawalla, Michael R Eber, Felicia M Forma, Jeffrey Sullivan, Pierre-Carl Michaud

Am J Manag Care· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections.
Marin L Schweizer, Eli N Perencevich, Michael R Eber, Xueya Cai, Michelle D Shardell

Antimicrob Resist Infect Control· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation.
Mintu P Turakhia, Matthew D Solomon, Mehul Jhaveri, Pamela Davis, Michael R Eber

Am Heart J· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010.
Nikolay P Braykov, Michael R Eber, Eili Y Klein, Daniel J Morgan, Ramanan Laxminarayan

Infect Control Hosp Epidemiol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment.
David C Grabowski, Darius N Lakdawalla, Dana P Goldman, Michael Eber, Larry Z Liu

Health Aff (Millwood)· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Disability burden of COPD.
Julia Thornton Snider, John A Romley, Ken S Wong, Jie Zhang, Michael Eber

COPD· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
John Romley, Dana Goldman, Michael Eber, Homa Dastani, Edward Kim

Am J Manag Care· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.
Tomas Philipson, Michael Eber, Darius N Lakdawalla, Mitra Corral, Rena Conti

Health Aff (Millwood)· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients.
Michael R Eber, Michelle Shardell, Marin L Schweizer, Ramanan Laxminarayan, Eli N Perencevich

PLoS One· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease?
Marin L Schweizer, Michael R Eber, Ramanan Laxminarayan, Jon P Furuno, Kyle J Popovich

Infect Control Hosp Epidemiol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999-2006.
Marc S Hoffmann, Michael R Eber, Ramanan Laxminarayan

Infect Control Hosp Epidemiol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia.
Michael R Eber, Ramanan Laxminarayan, Eli N Perencevich, Anup Malani

Arch Intern Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis